Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B

Ítems similars

• Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs
  per: Haurigot, Virginia, et al.
  Publicat: (2010)
• Translational Data from Adeno-Associated Virus-Mediated Gene Therapy of Hemophilia B in Dogs
  per: Nichols, Timothy C., et al.
  Publicat: (2015)
• Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
  per: Arruda, Valder R., et al.
  Publicat: (2003)
• Protein Replacement Therapy and Gene Transfer in Canine Models of Hemophilia A, Hemophilia B, von Willebrand Disease, and Factor VII Deficiency
  per: Nichols, Timothy C., et al.
  Publicat: (2009)
• Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model
  per: Arruda, Valder R., et al.
  Publicat: (2005)